Abeona Therapeutics Inc (ABEO)
4.40
-0.20
(-4.35%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.02
(+0.45%)
After-Hours: 20:00
Abeona Therapeutics 1 Year Total Returns (Daily): 48.65% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 48.65% |
| May 16, 2024 | 51.82% |
| May 15, 2024 | 52.92% |
| May 14, 2024 | 41.41% |
| May 13, 2024 | 44.78% |
| May 10, 2024 | 31.25% |
| May 09, 2024 | 39.94% |
| May 08, 2024 | 40.58% |
| May 07, 2024 | 39.02% |
| May 06, 2024 | 45.73% |
| May 03, 2024 | 48.39% |
| May 02, 2024 | 24.09% |
| May 01, 2024 | 20.68% |
| April 30, 2024 | 34.85% |
| April 29, 2024 | 12.05% |
| April 26, 2024 | 1.88% |
| April 25, 2024 | -2.15% |
| April 24, 2024 | -6.49% |
| April 23, 2024 | 5.90% |
| April 22, 2024 | 128.6% |
| April 19, 2024 | 140.3% |
| April 18, 2024 | 157.0% |
| April 17, 2024 | 164.3% |
| April 16, 2024 | 178.1% |
| April 15, 2024 | 173.8% |
| Date | Value |
|---|---|
| April 12, 2024 | 159.5% |
| April 11, 2024 | 167.7% |
| April 10, 2024 | 160.1% |
| April 09, 2024 | 164.8% |
| April 08, 2024 | 167.6% |
| April 05, 2024 | 164.8% |
| April 04, 2024 | 173.0% |
| April 03, 2024 | 184.5% |
| April 02, 2024 | 165.2% |
| April 01, 2024 | 173.8% |
| March 28, 2024 | 160.8% |
| March 27, 2024 | 169.9% |
| March 26, 2024 | 171.6% |
| March 25, 2024 | 173.1% |
| March 22, 2024 | 217.1% |
| March 21, 2024 | 207.3% |
| March 20, 2024 | 227.4% |
| March 19, 2024 | 216.7% |
| March 18, 2024 | 192.5% |
| March 15, 2024 | 229.4% |
| March 14, 2024 | 213.1% |
| March 13, 2024 | 227.9% |
| March 12, 2024 | 204.1% |
| March 11, 2024 | 190.3% |
| March 08, 2024 | 143.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.68%
Minimum
Feb 11 2022
242.5%
Maximum
Mar 01 2024
-35.69%
Average
-54.03%
Median
Jul 09 2021
1 Year Total Returns (Daily) Benchmarks
| T2 Biosystems Inc | -78.80% |
| INVO Bioscience Inc | -86.39% |
| Perspective Therapeutics Inc | 252.7% |
| Electromed Inc | 32.31% |
| Xtant Medical Holdings Inc | 14.30% |